L
Lila Sciences
Scientific superintelligence to tackle humanity's greatest challenges through AI-driven discovery and innovation
At a glance
- Founded
- 2022
- Headquarters
- Cambridge, United States
- Sector
- Biotech & Life Sciences
- Power Law
- Unicorn$1–10B valuation tier
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed8 investors entered at this stage
- MPModi Venture Partners
Flagship Pioneering
General Catalyst
ARK Invest- MPMarch Capital Partners
- BABlue Horizon Advisors
- AVAltitude Life Science Ventures
- SSState of Michigan Retirement Systems
Series A6 investors entered at this stage
- AFARK Venture Fund
- BRBraidwell
Alumni Ventures- NVNVentures
- CMCommon Metal
- NSNGS Super
Ownership
Estimated cap table from Dealroom's shareholder data — share of equity by holder. Stakes as last recorded by Dealroom (2026). Percentages are indicative.
Some investors are hidden on this public profile. See the full cap table on Dealroom →
Source: Dealroom Talent Intelligence.
Global footprint
team presence
across markets
Market sentiment
An AI-synthesised read of the highest-engagement posts about Lila Sciences on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Lila Sciences on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.